Dallas, TX, United States of America

Xiaoye Liu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoye Liu. Retrieved from https://idiyas.com/inventor/xiaoye-liu-hslrgrb2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaoye Liu

Introduction

Xiaoye Liu is an accomplished inventor based in Dallas, TX. He has made significant contributions to the field of biotechnology, particularly through his innovative research and development of novel antibodies.

Latest Patents

Xiaoye Liu holds a patent for "Novel LILRB2 Antibodies and Uses Thereof." This patent represents a crucial advancement in the understanding and application of antibodies in medical science. He has 1 patent to his name, showcasing his commitment to innovation.

Career Highlights

Xiaoye Liu is affiliated with The University of Texas System, where he continues to engage in groundbreaking research. His work has the potential to impact various therapeutic areas, particularly in immunology.

Collaborations

Xiaoye Liu collaborates with Ningyan Zhang, a talented woman in the field. Together, they contribute to advancing research and development in their respective areas of expertise.

Conclusion

Xiaoye Liu's contributions to biotechnology through his patent and collaboration with colleagues highlight his role as an innovative inventor. His work continues to pave the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…